240 related articles for article (PubMed ID: 26061247)
1. Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor.
Palmer WS; Poncet-Montange G; Liu G; Petrocchi A; Reyna N; Subramanian G; Theroff J; Yau A; Kost-Alimova M; Bardenhagen JP; Leo E; Shepard HE; Tieu TN; Shi X; Zhan Y; Zhao S; Barton MC; Draetta G; Toniatti C; Jones P; Geck Do M; Andersen JN
J Med Chem; 2016 Feb; 59(4):1440-54. PubMed ID: 26061247
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.
Bennett J; Fedorov O; Tallant C; Monteiro O; Meier J; Gamble V; Savitsky P; Nunez-Alonso GA; Haendler B; Rogers C; Brennan PE; Müller S; Knapp S
J Med Chem; 2016 Feb; 59(4):1642-7. PubMed ID: 25974391
[TBL] [Abstract][Full Text] [Related]
3. Development of small molecule inhibitors of BRPF1 and TRIM24 bromodomains.
Palmer WS
Drug Discov Today Technol; 2016 Mar; 19():65-71. PubMed ID: 27769360
[TBL] [Abstract][Full Text] [Related]
4. Discovery, optimization and evaluation of 1-(indolin-1-yl)ethan-1-ones as novel selective TRIM24/BRPF1 bromodomain inhibitors.
Xiang Q; Luo G; Zhang C; Hu Q; Wang C; Wu T; Xu H; Hu J; Zhuang X; Zhang M; Wu S; Xu J; Zhang Y; Liu J; Xu Y
Eur J Med Chem; 2022 Jun; 236():114311. PubMed ID: 35385803
[TBL] [Abstract][Full Text] [Related]
5. Structure-based discovery of selective BRPF1 bromodomain inhibitors.
Zhu J; Zhou C; Caflisch A
Eur J Med Chem; 2018 Jul; 155():337-352. PubMed ID: 29902720
[TBL] [Abstract][Full Text] [Related]
6. Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.
Poplawski A; Hu K; Lee W; Natesan S; Peng D; Carlson S; Shi X; Balaz S; Markley JL; Glass KC
J Mol Biol; 2014 Apr; 426(8):1661-76. PubMed ID: 24333487
[TBL] [Abstract][Full Text] [Related]
7. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I
Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712
[TBL] [Abstract][Full Text] [Related]
8. Twenty Crystal Structures of Bromodomain and PHD Finger Containing Protein 1 (BRPF1)/Ligand Complexes Reveal Conserved Binding Motifs and Rare Interactions.
Zhu J; Caflisch A
J Med Chem; 2016 Jun; 59(11):5555-61. PubMed ID: 27167503
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into recognition of acetylated histone ligands by the BRPF1 bromodomain.
Lubula MY; Eckenroth BE; Carlson S; Poplawski A; Chruszcz M; Glass KC
FEBS Lett; 2014 Nov; 588(21):3844-54. PubMed ID: 25281266
[TBL] [Abstract][Full Text] [Related]
10. Crystallization and preliminary X-ray diffraction analysis of the BRPF1 bromodomain in complex with its H2AK5ac and H4K12ac histone-peptide ligands.
Lubula MY; Poplawaski A; Glass KC
Acta Crystallogr F Struct Biol Commun; 2014 Oct; 70(Pt 10):1389-93. PubMed ID: 25286946
[TBL] [Abstract][Full Text] [Related]
11. The polar warhead of a TRIM24 bromodomain inhibitor rearranges a water-mediated interaction network.
Liu J; Li F; Bao H; Jiang Y; Zhang S; Ma R; Gao J; Wu J; Ruan K
FEBS J; 2017 Apr; 284(7):1082-1095. PubMed ID: 28207202
[TBL] [Abstract][Full Text] [Related]
12. Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).
Qin S; Jin L; Zhang J; Liu L; Ji P; Wu M; Wu J; Shi Y
J Biol Chem; 2011 Oct; 286(42):36944-55. PubMed ID: 21880731
[TBL] [Abstract][Full Text] [Related]
13. Bivalent interaction of the PZP domain of BRPF1 with the nucleosome impacts chromatin dynamics and acetylation.
Klein BJ; Muthurajan UM; Lalonde ME; Gibson MD; Andrews FH; Hepler M; Machida S; Yan K; Kurumizaka H; Poirier MG; Côté J; Luger K; Kutateladze TG
Nucleic Acids Res; 2016 Jan; 44(1):472-84. PubMed ID: 26626149
[TBL] [Abstract][Full Text] [Related]
14. Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.
Ullah M; Pelletier N; Xiao L; Zhao SP; Wang K; Degerny C; Tahmasebi S; Cayrou C; Doyon Y; Goh SL; Champagne N; Côté J; Yang XJ
Mol Cell Biol; 2008 Nov; 28(22):6828-43. PubMed ID: 18794358
[TBL] [Abstract][Full Text] [Related]
15. The BRPF1 bromodomain is a molecular reader of di-acetyllysine.
Obi JO; Lubula MY; Cornilescu G; Henrickson A; McGuire K; Evans CM; Phillips M; Boyson SP; Demeler B; Markley JL; Glass KC
Curr Res Struct Biol; 2020; 2():104-115. PubMed ID: 33554132
[TBL] [Abstract][Full Text] [Related]
16. Molecular Basis for the PZP Domain of BRPF1 Association with Chromatin.
Klein BJ; Cox KL; Jang SM; Côté J; Poirier MG; Kutateladze TG
Structure; 2020 Jan; 28(1):105-110.e3. PubMed ID: 31711755
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6/8 and bromodomain BRPF1.
Ghazy E; Zeyen P; Herp D; Hügle M; Schmidtkunz K; Erdmann F; Robaa D; Schmidt M; Morales ER; Romier C; Günther S; Jung M; Sippl W
Eur J Med Chem; 2020 Aug; 200():112338. PubMed ID: 32497960
[TBL] [Abstract][Full Text] [Related]
18. MOZ and MORF acetyltransferases: Molecular interaction, animal development and human disease.
Yang XJ
Biochim Biophys Acta; 2015 Aug; 1853(8):1818-26. PubMed ID: 25920810
[TBL] [Abstract][Full Text] [Related]
19. The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity.
Laue K; Daujat S; Crump JG; Plaster N; Roehl HH; ; Kimmel CB; Schneider R; Hammerschmidt M
Development; 2008 Jun; 135(11):1935-46. PubMed ID: 18469222
[TBL] [Abstract][Full Text] [Related]
20. Integrated virtual screening and MD simulation approaches toward discovering potential inhibitors for targeting BRPF1 bromodomain in hepatocellular carcinoma.
Barman S; Bardhan I; Padhan J; Sudhamalla B
J Mol Graph Model; 2024 Jan; 126():108642. PubMed ID: 37797430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
